Press Release Archives - Page 6 of 6

Adds unique gene-independent approach to treat the later stages of rod-cone dystrophies such as retinitis…

An abstract on rod-derived cone viability factor (RdCVF) in pig models of Retinitis Pigmentosa (RP)…

Three abstracts highlighting the company’s recent research into ocular diseases and its lead gene therapy…

SparingVision announces the conferences that its management team will be participating in in the first…

Former Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of…

Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board Paris, January…

• Dr. Florence Lorget to lead development sciences as Chief Development Sciences Officer • Dr.…

New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital with additional investment…

Paris, June 30th, 2020 – SparingVision, a biotechnology company specializing in the research and development…

Cookie	Duration	Description
__cf_bm	1 hour	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management. Further information: https://developers.cloudflare.com/fundamentals/reference/policies-compliances/cloudflare-cookies/#__cf_bm-cookie-for-cloudflare-bot-products
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category.
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category.
CookieLawInfoConsent	6 months	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.